Mark A. Ellenbogen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark A. Ellenbogen has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Christopher Cardoso
Centre for Research in Human Development, Department of Psychology, Concordia University, Montreal, Canada
17 shared publications- Sheilagh Hodgins
Département de psychiatrie, Université de Montréal, Montréal, Canada
16 shared publications Anne-Marie Linnen
Centre for Research in Human Development, Department of Psychology, Concordia University
14 shared publicationsLisa Serravalle
Department of Psychology, Concordia University, Montreal, QC, Canada
10 shared publicationsRidha Joober
The Douglas Research Centre, Department of Psychiatry, McGill University, Montréal, Canada
10 shared publicationsMark Anthony Orlando
Centre for Research in Human Development, Concordia University, Quebec, Montreal, Canada
7 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 191, 107904
Low levels of organization and consistency in the home in middle childhood predicts cortisol levels and internalizing symptoms 12 years later among the offspring of parents with bipolar disorder
- 25 May 2026
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 191, 107904
Open AccessLow levels of organization and consistency in the home in middle childhood predicts cortisol levels and internalizing symptoms 12 years later among the offspring of parents with bipolar disorder
- Open Access
- 14 May 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 187, 106749
Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials
- 14 May 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 187, 106749
Open AccessDoes intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials
- 4 May 2025
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 55 (3) , 327-350
Development and validation of the multidimensional Fear of Depression Recurrence Questionnaire (FoDRQ)
Despite high recurrence rates in major depressive disorder (MDD), little is known about the factors influencing recurrence. Understanding the changes that occur between major depressive episodes (MDEs) is imperative. It is possible that being fearful of experiencing another MDE may lead to cognitive and behavioural changes that increase MDD recurrence risk. There are no available tools designed to capture these fears. This study developed and validated a self-report questionnaire measuring fears of depression recurrence (FoDR). 552 participants remitted from MDD (75% female; Age 18-73, Mage = 29.5, SD = 9.2) participated. Separate samples were used for the exploratory factor analysis (n = 200) and confirmatory factor analysis (n = 352). Test-retest reliability was assessed (n = 244). The results supported the retention of a 24-item scale, the Fear of Depression Recurrence Questionnaire (FoDRQ), loading onto three factors (severity, content, triggers). The FoDRQ demonstrated excellent internal consistency and composite reliability, and acceptable test-retest reliability. The scale showed strong convergent and divergent validity across other validated measures. FoDRQ scores significantly predicted measures of experiential avoidance and mental health self-management. The FoDRQ has excellent psychometric properties and can be used to understand how FoDR may influence MDD outcomes, recurrence risk, and illness-related coping.
- 4 May 2025
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 55 (3) , 327-350
Development and validation of the multidimensional Fear of Depression Recurrence Questionnaire (FoDRQ)
Despite high recurrence rates in major depressive disorder (MDD), little is known about the factors influencing recurrence. Understanding the changes that occur between major depressive episodes (MDEs) is imperative. It is possible that being fearful of experiencing another MDE may lead to cognitive and behavioural changes that increase MDD recurrence risk. There are no available tools designed to capture these fears. This study developed and validated a self-report questionnaire measuring fears of depression recurrence (FoDR). 552 participants remitted from MDD (75% female; Age 18-73, Mage = 29.5, SD = 9.2) participated. Separate samples were used for the exploratory factor analysis (n = 200) and confirmatory factor analysis (n = 352). Test-retest reliability was assessed (n = 244). The results supported the retention of a 24-item scale, the Fear of Depression Recurrence Questionnaire (FoDRQ), loading onto three factors (severity, content, triggers). The FoDRQ demonstrated excellent internal consistency and composite reliability, and acceptable test-retest reliability. The scale showed strong convergent and divergent validity across other validated measures. FoDRQ scores significantly predicted measures of experiential avoidance and mental health self-management. The FoDRQ has excellent psychometric properties and can be used to understand how FoDR may influence MDD outcomes, recurrence risk, and illness-related coping.
- Open Access
- 14 September 2024
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 171, 107182
Hypothalamic-pituitary-adrenal axis function in the offspring of parents with bipolar disorder and the impact of the family environment: A pilot study of the Reducing Unwanted Stress in the Home (RUSH) prevention program
- 14 September 2024
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 171, 107182
Open AccessHypothalamic-pituitary-adrenal axis function in the offspring of parents with bipolar disorder and the impact of the family environment: A pilot study of the Reducing Unwanted Stress in the Home (RUSH) prevention program
- 29 August 2024
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 34 (4) , 1249-1265
Hypothalamic–pituitary–adrenal axis functioning in offspring of parents with a major affective disorder: a meta-analytic review
Because the offspring of parents with an affective disorder (OAD) are at high risk for developing mental disorders, and persons with an affective disorder (AD) show dysfunctional hypothalamic–pituitary–adrenal (HPA) axis activity, changes in HPA functioning in OAD might be an etiological risk factor that precedes the development of ADs. The primary aim of the meta-analysis was to quantitatively summarize the existing data on different indices of diurnal cortisol in the OAD. The secondary aim was to explore potential moderators of this relation. Following PRISMA guidelines, we included 26 studies (3052 offspring) on diurnal cortisol in our meta-analysis after an initial screening of 3408 articles. Intercept-only and meta-regression models were computed using the robust variance estimation method. Analyses examining mean cortisol levels at discrete timepoints, total cortisol output, and the cortisol rise in response to awakening (CAR) were conducted separately. The results demonstrated that the OAD had higher mean levels of cortisol at different timepoints throughout the day compared to controls (Hedge’s g = 0.21). There was evidence of publication bias in studies examining CAR, such that effect sizes were positively biased. The present findings are consistent with a meta-analysis showing elevated cortisol in youth having an AD. Notable limitations across studies include the method of cortisol measurement and assessment of ADs. Altogether, these results highlight the fact that increased cortisol levels may act as a potential neuroendocrine antecedent and/or risk factor for the development of ADs among high risk youth.
- 29 August 2024
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 34 (4) , 1249-1265
Hypothalamic–pituitary–adrenal axis functioning in offspring of parents with a major affective disorder: a meta-analytic review
Because the offspring of parents with an affective disorder (OAD) are at high risk for developing mental disorders, and persons with an affective disorder (AD) show dysfunctional hypothalamic–pituitary–adrenal (HPA) axis activity, changes in HPA functioning in OAD might be an etiological risk factor that precedes the development of ADs. The primary aim of the meta-analysis was to quantitatively summarize the existing data on different indices of diurnal cortisol in the OAD. The secondary aim was to explore potential moderators of this relation. Following PRISMA guidelines, we included 26 studies (3052 offspring) on diurnal cortisol in our meta-analysis after an initial screening of 3408 articles. Intercept-only and meta-regression models were computed using the robust variance estimation method. Analyses examining mean cortisol levels at discrete timepoints, total cortisol output, and the cortisol rise in response to awakening (CAR) were conducted separately. The results demonstrated that the OAD had higher mean levels of cortisol at different timepoints throughout the day compared to controls (Hedge’s g = 0.21). There was evidence of publication bias in studies examining CAR, such that effect sizes were positively biased. The present findings are consistent with a meta-analysis showing elevated cortisol in youth having an AD. Notable limitations across studies include the method of cortisol measurement and assessment of ADs. Altogether, these results highlight the fact that increased cortisol levels may act as a potential neuroendocrine antecedent and/or risk factor for the development of ADs among high risk youth.
- Open Access
- 6 March 2024
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (9) , 2122-2132
The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial
Background: Although both pharmacotherapy and psychological treatments are considered to be efficacious in the treatment of major depressive disorder (MDD), one third of patients do not respond to treatment and many experience residual symptoms post-treatment. In this double-blind placebo-controlled randomized control trial (RCT), we assessed whether intranasal oxytocin (OT) augments the therapeutic efficacy of psychotherapy for MDD and improves the therapeutic alliance.Methods: Twenty-three volunteers (12 female) with MDD underwent 16 sessions of interpersonal therapy. Prior to each session, volunteers self-administered 24 International Units of intranasal OT (n = 12; Syntocinon) or placebo (n = 11). Depressive symptoms were assessed with the Inventory of Depressive Symptomatology at pre- and post-treatment, and at a six month follow-up.Results: Multilevel modeling found a significant effect of OT on the negative slope of depressive symptoms over time (p < 0.05), with medium-large effect sizes at post-treatment (Cohen's d = 0.75) and follow-up (Cohen's d = 0.82). Drug intervention also predicted the intercept when examining the weekly ratings of the therapeutic alliance (p < 0.05), such that volunteers receiving OT, relative to placebo, reported improved therapeutic alliance at session 1. The agreement of goals between therapists and participants, a facet of the therapeutic alliance, mediated the relationship between drug intervention and clinical outcome.Conclusion: In this pilot study, the administration of intranasal OT, relative to placebo, improved the therapeutic alliance at the beginning of therapy and therapeutic efficacy of psychotherapy in persons with MDD. Future RCTs should attempt to replicate these findings in larger samples with different therapeutic modalities (ClinicalTrials.gov: NCT02405715).
- 6 March 2024
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (9) , 2122-2132
Open AccessThe effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial
Background: Although both pharmacotherapy and psychological treatments are considered to be efficacious in the treatment of major depressive disorder (MDD), one third of patients do not respond to treatment and many experience residual symptoms post-treatment. In this double-blind placebo-controlled randomized control trial (RCT), we assessed whether intranasal oxytocin (OT) augments the therapeutic efficacy of psychotherapy for MDD and improves the therapeutic alliance.Methods: Twenty-three volunteers (12 female) with MDD underwent 16 sessions of interpersonal therapy. Prior to each session, volunteers self-administered 24 International Units of intranasal OT (n = 12; Syntocinon) or placebo (n = 11). Depressive symptoms were assessed with the Inventory of Depressive Symptomatology at pre- and post-treatment, and at a six month follow-up.Results: Multilevel modeling found a significant effect of OT on the negative slope of depressive symptoms over time (p < 0.05), with medium-large effect sizes at post-treatment (Cohen's d = 0.75) and follow-up (Cohen's d = 0.82). Drug intervention also predicted the intercept when examining the weekly ratings of the therapeutic alliance (p < 0.05), such that volunteers receiving OT, relative to placebo, reported improved therapeutic alliance at session 1. The agreement of goals between therapists and participants, a facet of the therapeutic alliance, mediated the relationship between drug intervention and clinical outcome.Conclusion: In this pilot study, the administration of intranasal OT, relative to placebo, improved the therapeutic alliance at the beginning of therapy and therapeutic efficacy of psychotherapy in persons with MDD. Future RCTs should attempt to replicate these findings in larger samples with different therapeutic modalities (ClinicalTrials.gov: NCT02405715).
- Open Access
- 27 February 2023
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 11 (1) , 1-11
Reduced parenting stress following a prevention program decreases internalizing and externalizing symptoms in the offspring of parents with bipolar disorder
Background: Offspring of parents with bipolar disorder (OBD) are at risk for developing mental disorders, and the literature suggests that parenting stress may represent an important risk factor linking parental psychopathology to offspring psychopathology. We aimed to investigate whether improvements in parenting stress mediated the relationship between participation in a prevention program and offspring internalizing and externalizing symptoms at follow-up. Methods: Families having a parent with BD (N = 25) underwent a 12-week prevention program. Assessments were conducted at pre-intervention, post-intervention, and at 3- and 6-month follow-ups. Families of parents with no affective disorders (i.e., control families) served as a comparison sample (N = 28). The Reducing Unwanted Stress in the Home (RUSH) program aimed to teach communication, problem-solving, and organization skills to improve the rearing environment. Measures included the Parenting Stress Index—4th Edition, the Behaviour Assessment Scales for Children—2nd Edition, and the UCLA Life Stress Interview. Results: Families having a parent with BD reported more parenting stress at pre-intervention, and more change across time, than control families. Improvements in parenting stress mediated the relationship between participation in the intervention and reduced offspring internalizing and externalizing symptoms. While families having a parent with BD reported more chronic interpersonal stress at pre-intervention, no intervention effects were found. Conclusions: The findings demonstrate that a preventative intervention targeting parenting stress in families may serve to prevent the development of mental disorders in at-risk children.
- 27 February 2023
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 11 (1) , 1-11
Open AccessReduced parenting stress following a prevention program decreases internalizing and externalizing symptoms in the offspring of parents with bipolar disorder
Background: Offspring of parents with bipolar disorder (OBD) are at risk for developing mental disorders, and the literature suggests that parenting stress may represent an important risk factor linking parental psychopathology to offspring psychopathology. We aimed to investigate whether improvements in parenting stress mediated the relationship between participation in a prevention program and offspring internalizing and externalizing symptoms at follow-up. Methods: Families having a parent with BD (N = 25) underwent a 12-week prevention program. Assessments were conducted at pre-intervention, post-intervention, and at 3- and 6-month follow-ups. Families of parents with no affective disorders (i.e., control families) served as a comparison sample (N = 28). The Reducing Unwanted Stress in the Home (RUSH) program aimed to teach communication, problem-solving, and organization skills to improve the rearing environment. Measures included the Parenting Stress Index—4th Edition, the Behaviour Assessment Scales for Children—2nd Edition, and the UCLA Life Stress Interview. Results: Families having a parent with BD reported more parenting stress at pre-intervention, and more change across time, than control families. Improvements in parenting stress mediated the relationship between participation in the intervention and reduced offspring internalizing and externalizing symptoms. While families having a parent with BD reported more chronic interpersonal stress at pre-intervention, no intervention effects were found. Conclusions: The findings demonstrate that a preventative intervention targeting parenting stress in families may serve to prevent the development of mental disorders in at-risk children.
- 13 May 2022
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 142, 105796
Intranasal oxytocin alters attention to emotional facial expressions, particularly for males and those with depressive symptoms
- 13 May 2022
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 142, 105796
Intranasal oxytocin alters attention to emotional facial expressions, particularly for males and those with depressive symptoms
- 9 April 2021
- Published by Springer Nature in Research on Child and Adolescent Psychopathology
- Vol. 49 (6) , 833
Correction to: Improved Parent–Child Interactions Predict Reduced Internalizing Symptoms Among the Offspring of Parents with Bipolar Disorder Undergoing a Prevention Program: A Proof‑of‑Concept Study
- 9 April 2021
- Published by Springer Nature in Research on Child and Adolescent Psychopathology
- Vol. 49 (6) , 833
Correction to: Improved Parent–Child Interactions Predict Reduced Internalizing Symptoms Among the Offspring of Parents with Bipolar Disorder Undergoing a Prevention Program: A Proof‑of‑Concept Study